文献速递药物不良反应与药物警戒

医学生作为初级药物不良事件管理者促进药物不良反应上报

Medical students as junior adverse drug event managers facilitating reporting of ADRs.
PubMed 文献 · Br J Clin Pharmacol · 2021-05-26

本研究评估J-ADEM团队(由医学生组成)在医院两个病房筛查并上报药物不良反应(ADR)的效果。2018年8月至2020年1月共筛查209例患者,上报101例ADR,其中33例为既往未识别的严重ADR,并使ADR上报数量增加300%。

要点

  • 医学生可有效筛查并上报住院患者ADR,发现既往未识别的严重ADR。
  • J-ADEM团队使ADR上报数量增加300%,并帮助优化10%ADR的治疗。
  • 上报ADR多为A型(66%)、中重度(85%)且可避免(69%)。

核心结论

  • 医学生能够筛查患者ADR、识别既往未发现的ADR并协助优化ADR管理,使ADR上报数量显著增加300%。

研究设计与样本

  • J-ADEM团队由医学生组成,负责管理并上报住院患者ADR;2018年8月至2020年1月在学术医院两个病房筛查209例患者,对筛查和上报的ADR匿名记录并描述性分析。

主要发现

  • J-ADEM团队共上报101例ADR。
  • 67%的ADR由医疗专业人员首先识别后由J-ADEM团队上报,团队还额外上报了33例既往未识别的严重ADR。
  • 在10%的上报ADR中,J-ADEM团队帮助优化了ADR治疗。
  • 78%的ADR报告记录良好,66%为A型,85%为中重度,69%为可避免反应。

临床怎么用

  • 可考虑将医学生纳入ADR筛查与上报流程,以补充现有药物警戒工作并提高上报率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Junior Adverse Drug Event Manager (J-ADEM) team is a multifaceted intervention focusing on real-life education for medical students that has been shown to assist healthcare professionals in managing and reporting suspected adverse drug reactions (ADRs) to the Netherlands Pharmacovigilance Centre Lareb. The aim of this study was to quantify and describe the ADRs reported by the J-ADEM team and to determine the clinical potential of this approach. The J-ADEM team consisted of medical students tasked with managing and reporting ADRs in hospitalized patients. All ADRs screened and reported by J-ADEM team were recorded anonymously, and categorized and analysed descriptively. From August 2018 through January 2020, 209 patients on two wards in an academic hospital were screened for ADR events. The J-ADEM team reported 101 ADRs. Although most ADRs (67%) were first identified by healthcare professionals and then reported by the J-ADEM team, the team also reported an additional 33 not previously identified serious ADRs. In 10% of all reported ADRs, the J-ADEM team helped optimize ADR treatment. The ADR reports were largely well-documented (78%), and ADRs were classified as type A (66%), had a moderate or severe severity (85%) and were predominantly avoidable reactions (69%). This study shows that medical students are able to screen patients for ADRs, can identify previously undetected ADRs and can help optimize ADR management. They significantly increased (by 300%) the number of ADR reports submitted, showing that the J-ADEM team can make a valuable clinical contribution to hospital care.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Reumerman MO, Tichelaar J, Richir MC, et al. Medical students as junior adverse drug event managers facilitating reporting of ADRs. Br J Clin Pharmacol. 2021. PMID: 33955031. doi:10.1111/bcp.14885

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。